Patent · US Active

Method for preparing a concentrate of factor XI

US9181323B2 · kind B2 · utility

0Cited by
1References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 19, 2012
Grant dateNov 10, 2015
Priority date
Expiry dateApr 19, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/21027
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention concerns a concentrate of human Factor XI having high specific activity prepared using a method comprising a filtration-adsorption step and a chromatography step on cation exchange resin. The concentrate obtained is fully adapted for therapeutic use as substitution therapy in cases of Factor XI deficiency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.